EP1210951 - Bibliographic data
Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone
Last update | 05/05/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Européen |
(73) Holder |
PFIZER PRODUCTS INC. Eastern Point Road
Groton, CT 06340
États-Unis d'Amérique
|
---|---|
(72) Inventors |
McLean, David Burton, c/o Pfizer Global Res.& Dev. Eastern Point Road
Groton, Connecticut 06340
États-Unis d'Amérique
|
(74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
(21) Request number | EP01309457.8 |
---|---|
(22) Request date | 08/11/2001 |
(11) Publication number | EP1210951 |
---|---|
Publication date | 02/02/2005 |
(54) Title of the invention | Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone |
---|---|
(51) International classification | None |
International classification (before reform) | , , , , , , , , , , , , , , , , , , |
Claimed priority |
(31) Number: 250071 P |
---|---|
Initial application | None |
Divisional application | None |
Expected annuity |
Annuity: 6 -
Amount: 70 € -
Due date 30/11/2006
Surtax: 6 - Amount: 14 € - Due date 31/05/2007 |
---|---|
Last annuity | Annuity: 5 - Payment date 14/02/2005 |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/1, of 31/03/2005 |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 02/02/2005 Déchéance du brevet d'invention après période de grâce - Legal date 30/11/2006 Entrée en période de grâce du brevet d'invention - Legal date 30/11/2006 |